share_log

SVB Leerink Maintains Outperform on Merck & Co, Raises Price Target to $110

Benzinga Real-time News ·  Sep 30, 2022 04:56

SVB Leerink analyst Daina Graybosch maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $109 to $110.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment